SCHEMBL20529938

SCHEMBL20529938

O=[SH](=O)Cc1ccc(C2=C(c3ccc(F)cc3)CC3(CC3)C2)cc1

nearest known ligand 0.54

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 20/20 0.54
PTGS1 P23219 13/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20529940 0.82 PTGS2 (0.60) PTGS2PTGS1
SCHEMBL19953393 0.79 MAPK14 (0.51) PTGS2PTGS1
SCHEMBL14198825 0.77 IDO1 (0.46)
SCHEMBL20529853 0.75 PTGS1 (0.54) PTGS2PTGS1
SCHEMBL6648605 0.73 PTGS2 (0.58) PTGS2PTGS1
SCHEMBL8266066 0.73 PTGS2 (0.63) PTGS2PTGS1
SCHEMBL21113575 0.70 PTGS1 (0.38) PTGS2PTGS1
SCHEMBL215231 0.70 PTGS2 (1.00) PTGS2PTGS1
SCHEMBL213644 0.70 PTGS2 (1.00) PTGS2PTGS1
SCHEMBL28997882 0.66 ALDH1A1 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018187698-A2 COMBINATION THERAPIES USING CASPASE-1 DEPENDENT ANTICANCER AGENTS AND PGE2 ANTAGONISTS TRUSTEES OF TUFTS COLLEGE (US) 2018-10-11 WO disclosed